Framework agreement for medicines with the active substance perindopril arginine, amlodipine and indapamide

Summary

The tender concerns the supply of medicines under a framework agreement for the active substance perindopril arginine + amlodipine + indapamide. The bidder should note that DAK-Gesundheit intends to conclude agreements with as many interested pharmaceutical companies as possible, and that the contract runs from 1 September 2026 to 31 August 2028, with an option to extend it once by 12 months. The exact qualification and compliance requirements must be checked in the tender documents.